Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

REGN

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REGN
DateTimeSourceHeadlineSymbolCompany
27/05/202009:55PR Newswire (US)Regeneron Announces Pricing of Secondary Offering of its Common Stock Held by SanofiNASDAQ:REGNRegeneron Pharmaceuticals Inc
27/05/202002:25Dow Jones NewsFDA Approves Dupixent for Some Children With Atopic DermatitisNASDAQ:REGNRegeneron Pharmaceuticals Inc
27/05/202001:39PR Newswire (US)FDA Approves Dupixent® (dupilumab) as First Biologic Medicine for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic...NASDAQ:REGNRegeneron Pharmaceuticals Inc
27/05/202000:28Dow Jones NewsRegeneron Shares Fall as Partner Sanofi Moves to Sell StakeNASDAQ:REGNRegeneron Pharmaceuticals Inc
26/05/202020:17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:REGNRegeneron Pharmaceuticals Inc
26/05/202020:12Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:REGNRegeneron Pharmaceuticals Inc
26/05/202020:09Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:REGNRegeneron Pharmaceuticals Inc
26/05/202003:49Dow Jones NewsSanofi to Sell Equity Investment in RegeneronNASDAQ:REGNRegeneron Pharmaceuticals Inc
26/05/202002:40PR Newswire (US)Regeneron Announces Secondary Offering of its Common Stock Held by Sanofi and $5 Billion Stock RepurchaseNASDAQ:REGNRegeneron Pharmaceuticals Inc
23/05/202009:34Dow Jones NewsSanofi, Regeneron See Positive Results From Dupixent Phase 3 TrialNASDAQ:REGNRegeneron Pharmaceuticals Inc
23/05/202008:47PR Newswire (US)Dupixent® (dupilumab) Eosinophilic Esophagitis Trial Meets Both Co-Primary EndpointsNASDAQ:REGNRegeneron Pharmaceuticals Inc
23/05/202008:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
23/05/202008:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
16/05/202006:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
14/05/202007:00PR Newswire (US)Regeneron Presentations at ASCO 2020 Showcase Diverse Clinical Oncology PortfolioNASDAQ:REGNRegeneron Pharmaceuticals Inc
12/05/202006:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
11/05/202021:00PR Newswire (US)Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research CollaborationNASDAQ:REGNRegeneron Pharmaceuticals Inc
09/05/202006:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
09/05/202006:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
09/05/202006:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
08/05/202008:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
08/05/202006:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/05/202006:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
06/05/202002:29Dow Jones NewsRegeneron Pharmaceuticals Up Over 6%, On Pace for Highest Close Since November 2015 -- Data TalkNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/05/202000:57Dow Jones NewsRegeneron, Sanofi Report Positive Libtayo Results in Advanced Basal Cell CarcinomaNASDAQ:REGNRegeneron Pharmaceuticals Inc
05/05/202021:52Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:REGNRegeneron Pharmaceuticals Inc
05/05/202021:37Dow Jones NewsRegeneron 1Q Profit, Sales Beat ForecastsNASDAQ:REGNRegeneron Pharmaceuticals Inc
05/05/202021:35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
05/05/202021:32Dow Jones NewsRegeneron Plans Human Trials of Drug to Prevent, Treat Covid-19NASDAQ:REGNRegeneron Pharmaceuticals Inc
05/05/202020:30PR Newswire (US)Regeneron Reports First Quarter 2020 Financial and Operating ResultsNASDAQ:REGNRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REGN